Children's Health | Headaches, Phase III
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)
What is the purpose of this trial?
The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.
- Trial withEli Lilly and Company
- Ages6 years - 17 years
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact email@example.com, or call 877.978.8343 for more information.
- Last Updated12/22/2022
- Study HIC#2000028680